Supakarn Chamni - Publications

Molecular networking-assisted isolation, structural elucidation, and bioactivity evaluation of new diterpenoids from Chaetocarpus castanocarpus.

Journal: Natural product research

Published: May 14, 2026

Development of piperine/HPβCD-loaded PVA-coated iron oxide nanoparticles in in situ gel for enhanced retinal delivery and anti-VEGF activity.

Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V

Published: August 18, 2025

Mechanistic study of α-mangostin derivatives as potent α-glucosidase inhibitors.

Journal: Molecular diversity

Published: December 23, 2024

Jorunnamycin A induces apoptosis in pancreatic ductal adenocarcinoma cells, spheroids, and patient-derived organoids by modulating KRAS-mediated survival pathways.

Journal: Scientific reports

Published: December 10, 2024

Microbiome profiling and Actinomycetes isolation from tropical marine sponges.

Journal: AIMS microbiology

Published: November 22, 2024

Asiatic acid methyl ester, a new asiaticoside derivative, induces osteogenic differentiation of hPDLCs.

Journal: Archives of oral biology

Published: November 08, 2024

Exploring mimosamycin as a Janus kinase 2 inhibitor: A combined computational and experimental investigation.

Journal: Computational biology and chemistry

Published: October 28, 2024

Enhancing gut microbiota and microbial function with inulin supplementation in children with obesity.

Journal: International journal of obesity (2005)

Published: March 29, 2024

Alpha and gamma mangostins inhibit wild-type B SARS-CoV-2 more effectively than the SARS-CoV-2 variants and the major target is unlikely the 3C-like protease.

Journal: Heliyon

Published: March 06, 2024

Inulin supplementation exhibits increased muscle mass via gut-muscle axis in children with obesity: double evidence from clinical and in vitro studies.

Journal: Scientific reports

Published: December 05, 2023

Hyaluronic Acid Nanogels: A Promising Platform for Therapeutic and Theranostic Applications.

Journal: Pharmaceutics

Published: November 02, 2023

A combination of structure-based virtual screening and experimental strategies to identify the potency of caffeic acid ester derivatives as SARS-CoV-2 3CLpro inhibitor from an in-house database.

Journal: Biophysical chemistry

Published: July 10, 2023